Urinary biological monitoring markers of anticancer drug exposure in oncology nurses.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 8179062.
- Also identified by PMC identifier 1615027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
People handling anticancer drugs or their wastes may absorb these potent genotoxic agents. The aim of this study was to determine the utility of some general urinary markers among 24 female oncology nurses handling these drugs in comparison with 25 "unexposed" nurses. The markers were the Salmonella typhimurium reverse and forward mutation assays, total thioethers, and D-glucaric acid. The reverse mutation assay was the most specific and sensitive marker for anti-cancer drug exposure. Use of the marker battery was no great advantage as a screening tool relative to use of the reverse mutation assay alone. Better recording of work practices in nurse work logs would have improved interpretation of results.
Medical subject headings
- Antineoplastic Agents
- Environmental Monitoring
- Occupational Exposure
- Oncology Nursing